RNAi screening libraries are a collection of genes utilized by the RNA interference (RNAi) pathway. The RNAi pathway is a biological process in which RNA molecules inhibit gene expression or translation by neutralizing targeted mRNA molecules. These products include various human CRISPR libraries ideal for genetic screening.
96- or 384-well Plate (2)
96-well Plate (3)
gRNA (3)
siRNA (2)
DNA (1)
Stock up on essentials to piece your discovery together (9)
The award-winning Invitrogen™ LentiArray™ Human Whole Genome Library targets 18,453 genes with up to 4 gRNA per gene target (pooled in a single well) for a total of 73,812 gRNAs.
Silencer™ siRNA Libraries feature combinations of Silencer™ Pre-designed siRNAs, and when available, Silencer™ Validated siRNAs, in 96-well or 384-well plates.
The Invitrogen™ LentiArray™ Human Cell Surface Protein Library targets 778 genes with up to 4 gRNA per gene target (pooled in a single well) for a total of 3,112 gRNAs. Libraries are delivered as 100 μL of ready to use lentiviral particles per gene target.
The Invitrogen™ LentiArray™ Human DNA Damage Response Library targets 561 genes with up to 4 gRNA per gene target (pooled in a single well) for a total of 2,244 gRNAs. Libraries are delivered as 100 μL of ready to use lentiviral particles per gene target.
The award-winning Invitrogen™ LentiArray™ Human Druggable Genome Library targets 10,132 genes with up to 4 gRNA per gene target (pooled in a single well) for a total of 40,512 gRNAs.
The award-winning Invitrogen™ LentiArray™ Human Membrane Trafficking Library targets 141 genes with up to 4 gRNA per gene target (pooled in a single well) for a total of 564 gRNAs. Libraries are delivered as 100 μL of ready to use lentiviral particles per gene target.
The Invitrogen™ LentiArray™ Human Ubiquitin Library targets 943 genes with up to 4 gRNA per gene target (pooled in a single well) for a total of 3,722 gRNAs. Libraries are delivered as 100 μL of ready to use lentiviral particles per gene target.
The Invitrogen™ LentiArray™ Human Cell Cycle Library targets 1,444 genes with up to 4 gRNA per gene target (pooled in a single well) for a total of 5,776 gRNAs. Libraries are delivered as 100 μL of ready to use lentiviral particles per gene target.
The award-winning Invitrogen™ LentiArray™ Human Druggable Genome Library targets 10,132 genes with up to 4 gRNA per gene target for a total of 40,512 gRNAs.
The Invitrogen™ LentiArray™ Human Kinase CRISPR Library targets 822 genes with up to 4 gRNA per gene target (pooled in a single well) for a total of 3,288 gRNAs. Libraries are delivered as 100 μL of ready to use lentiviral particles per gene target.
The Invitrogen™ LentiArray™ Human Phosphatase Library targets 288 genes with up to 4 gRNA per gene target (pooled in a single well) for a total of 1,152 gRNAs. Libraries are delivered as 100 μL of ready to use lentiviral particles per gene target.
The Invitrogen™ LentiArray™ Human Transcription Factor Library targets 1,817 genes with up to 4 gRNA per gene target (pooled in a single well) for a total of 7,268 gRNAs. Libraries are delivered as 100 μL of ready to use lentiviral particles per gene target.
The Invitrogen™ LentiArray™ Human Drug Transporter Library targets 98 genes with up to 4 gRNA per gene target (pooled in a single well) for a total of 392 gRNAs. Libraries are delivered as 100 μL of ready to use lentiviral particles per gene target.
The Invitrogen™ LentiArray™ Human Protease Library targets 475 genes with up to 4 gRNA per gene target (pooled in a single well) for a total of 1,900 gRNAs. Libraries are delivered as 100 μL of ready to use lentiviral particles per gene target.
Silencer siRNA libraries provide guaranteed silencing across a range of popular gene family subsets and pathways to accelerate your functional genomics studies., If you’re ready to start screening with a pre-defined collection or want to request a custom library, request a quote now!
Silencer Select siRNAs incorporate the latest improvements in siRNA design, off-target effect prediction algorithms, and chemical modifications to yield siRNAs with unrivalled efficacy, potency, and specificity.